bluebird bio, Inc.·4

Feb 18, 5:22 PM ET

Burnett Katy 4

4 · bluebird bio, Inc. · Filed Feb 18, 2021

Insider Transaction Report

Form 4
Period: 2021-02-16
Burnett Katy
Principal Accounting Officer
Transactions
  • Award

    Common Stock

    2021-02-16+2,0003,188 total
  • Award

    Common Stock

    2021-02-16+1,4274,615 total
  • Sale

    Common Stock

    2021-02-17$28.16/sh518$14,5884,097 total
Footnotes (4)
  • [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2022, 25% on 01/04/2023, 25% on 01/04/2024, and 25% on 01/04/2025.
  • [F2]Immediately vested restricted stock unit reflecting the equity portion of the reporting person's 2020 performance compensation.
  • [F3]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F4]The range in prices for the transaction reported on this line was $27.97 to $28.54. The average weighted price was $28.1613. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

2 files